跳至主要内容
临床试验/NCT00617019
NCT00617019已完成不适用

A Cross-sectional, Retrospective Screening and Case-control Study Examining the Frequency of, and Risk Factors Associated With, Impulse Control Disorders in Parkinson's Disease Patients Treated With MIRAPEX® (Pramipexole) and Other Anti-parkinson Agents (DOMINION Study)

Boehringer Ingelheim49 个研究点 分布在 2 个国家目标入组 3,234 人开始时间: 2006年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
3,234
试验地点
49
主要终点
Occurrence of current ImpulseControl Disorder(ICD) assessed via + res. of Modif.Massachusetts Gambling Screen,Modif.Minnesota Impulsive Disorder Interview for Sexuality,Modif.MIDI for Compulsive Buying,DSM-IV binge-eating research criteria questionnaire

研究概览

简要总结

The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Cross Sectional

入排标准

年龄范围
30 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Observation Criteria:
  • Male or female outpatients, aged 30 to 75 years of age, with idiopathic PD. Patients must be selected on the basis of a prospective recruitment plan documented at the site, with the objective of obtaining an unbiased representative sample.
  • Patients must have been treated with anti-parkinson medication for a period of one year or greater and demonstrated a treatment response, in the opinion of the Investigator.
  • Patients must be willing and able to comply with study procedures. Patients must be willing and able to give meaningful, written informed consent. This must be completed prior to beginning any study procedures, in accordance with GCP and local legislation.

排除标准

  • 未提供

结局指标

主要结局

Occurrence of current ImpulseControl Disorder(ICD) assessed via + res. of Modif.Massachusetts Gambling Screen,Modif.Minnesota Impulsive Disorder Interview for Sexuality,Modif.MIDI for Compulsive Buying,DSM-IV binge-eating research criteria questionnaire

时间窗: 6 months

次要结局

  • The occurrence of a past (since onset of PD) ICD(6 months)
  • Demographic and medical history measures(up to 14 days after Visit 1)
  • Scores on psychiatric/neuropsychological instruments/tests(up to 14 days after Visit 1)

研究者

申办方类型
Industry

研究点 (49)

Loading locations...

相似试验